Xoma | XOMA - Market Capitalization

Stock Price
26.42
Daily Change
-0.03 -0.11%
Monthly
6.28%
Yearly
21.81%
Q1 Forecast
24.75

Xoma reported $307.5M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Agenus USD 40M 24M Mar/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Ardelyx USD 1.33B 390M Sep/2025
aTyr Pharma USD 71M 63M Sep/2025
BioMarin Pharmaceutical USD 11.76B 348M Mar/2026
Celldex Therapeutics USD 1.81B 87M Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Emergent BioSolutions USD 125M 51M Dec/2023
Incyte USD 19.39B 2.83B Dec/2025
MacroGenics USD 106M 29M Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Novartis USD 246.07B 11.81B Sep/2025
Pfizer USD 141.57B 6.48B Dec/2025
Prothena USD 525M 198M Sep/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025